Biology of Sport

The genetic landscape of injury-resistant variants in elite game-based athletes

Luigi Casillo 1
,
Giovanni Malerba 1
,
Ekaterina A. Semenova 2
,
George John 3
,
Rinat A. Yusupov 4
,
Simone Accordini 5
,
Andrey K. Larin 6
,
Nickolay A. Kulemin 6
,
Edward V. Generozov 6
,
Ildus I. Ahmetov 6, 7, 8, 9

  1. GM Lab, Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, 37134 Verona, Italy

  2. Research Institute of Physical Culture and Sport, Volga Region State University of Physical Culture, Sport and Tourism, 420010 Kazan, Russia

  3. Transform Specialist Medical Centre, Dubai 119190, United Arab Emirates

  4. Department of Physical Culture and Sport, Kazan National Research Technical University Named After A.N. Tupolev-KAI, 420111 Kazan, Russia

  5. Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy

  6. Department of Molecular Biology and Genetics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia

  7. Laboratory of Genetics of Aging and Longevity, Kazan State Medical University, 420012 Kazan, Russia

  8. Sports Genetics Laboratory, St Petersburg Research Institute of Physical Culture, 191040 St Petersburg, Russia

  9. Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool L3 5AF, UK

Biol Sport. 2027;44:201–214

DOI: https://doi.org/10.5114/biolsport.2027.165696
Data publikacji online: 2026/10/12
Article file
13_05751_Article.pdf
  1. Leppänen M, Pasanen K, Kannus P, Vasankari T, Kujala U, Heinonen A, Parkkari J. Epidemiology of overuse injuries in youth team sports: A 3-year prospective study. Int J Sports Med. 2017 Oct; 38(11):847–56. doi: 10.1055/s-0043-114864
  2. Bahr R, Holme I. Risk factors for sports injuries — a methodological approach. Br J Sports Med. 2003 Oct; 37(5):384–92. doi: 10.1136/bjsm.37.5.384.
  3. Theisen D, Frisch A, Malisoux L, Urhausen A, Croisier JL, Seil R. Injury risk is different in team and individual youth sport. J Sci Med Sport. 2013 May; 16(3):200–4. doi: 10.1016 /j.jsams.2012.07.007.
  4. Junge A, Langevoort G, Pipe A, Peytavin A, Wong F, Mountjoy M, Beltrami G, Terrell R, Holzgraefe M, Charles R, Dvorak J. Injuries in team sport tournaments during the 2004 olympic games. Am J Sports Med. 2006 Apr; 34(4):565–76. doi: 10.1177/0363546505281807.
  5. Zech A, Hollander K, Junge A, Steib S, Groll A, Heiner J, Nowak F, Pfeiffer D, Rahlf AL. Sex differences in injury rates in team-sport athletes: A systematic review and meta-regression analysis. J Sport Health Sci. 2022 Jan; 11(1):104–14. doi: 10.1016/j.jshs .2021.04.003.
  6. Markström JL, Grip H, Schelin L, Häger CK. Dynamic knee control and movement strategies in athletes and non-athletes in side hops: Implications for knee injury. Scand J Med Sci Sports. 2019 Aug; 29(8):1181–9. doi: 10.1111 /sms.13432.
  7. Magnusson K, Turkiewicz A, Hughes V, Frobell R, Englund M. High genetic contribution to anterior cruciate ligament rupture: Heritability ~69%. Br J Sports Med. 2021 Apr; 55(7):385–9. doi: 10.1136/bjsports-2020-102392.
  8. Vaughn NH, Stepanyan H, Gallo RA, Dhawan A. Genetic factors in tendon injury: A systematic review of the literature. Orthop J Sports Med. 2017 Aug 1; 5(8):2325967117724416. doi: 10.1177/2325967117724416
  9. Ahmetov II, Hall ECR, Semenova EA, Pranckevičienė E, Ginevičienė V. Advances in sports genomics. In: Advances in clinical chemistry [Internet]. Elsevier; 2022 [cited 2024 May 15]. p. 215–63. Available from: https://linkinghub.elsevier.com/retrieve/ pii/S0065242321000573 doi: 10.1016/bs.acc.2021.07.004.
  10. Al-Khelaifi F, Yousri NA, Diboun I, Semenova EA, Kostryukova ES, Kulemin NA, Borisov OV, Andryushchenko LB, Larin AK, Generozov EV, Miyamoto-Mikami E, Murakami H, Zempo H, Miyachi M, Takaragawa M, Kumagai H, Naito H, Fuku N, Abraham D, Hingorani A, Donati F, Botrè F, Georgakopoulos C, Suhre K, Ahmetov II, Albagha O, Elrayess MA. Genome-Wide Association Study reveals a novel association between MYBPC3 gene polymorphism, endurance athlete status, aerobic capacity and steroid metabolism. Front Genet. 2020 Jun 16; 11:595. doi: 10.3389/fgene.2020.00595.
  11. Petr M, Thiel D, Kateřina K, Brož P, Malý T, Zahálka F, Vostatková P, Wilk M, Chycki J, Stastny P. Speed and power-related gene polymorphisms associated with playing position in elite soccer players. Biol Sport. 2022 Mar; 39(2):355–66. doi: 10.5114/ biolsport.2022.105333 PubMed PMID: 35309536; PubMed Central PMCID: PMC8919892.
  12. Semenova EA, Zempo H, Miyamoto-Mikami E, Kumagai H, Larin AK, Sultanov RI, Babalyan KA, Zhelankin AV, Tobina T, Shiose K, Kakigi R, Tsuzuki T, Ichinoseki-Sekine N, Kobayashi H, Naito H, Burniston J, Generozov EV, Fuku N, Ahmetov II. Genome-Wide Association Study identifies CDKN1A as a novel locus associated with muscle fiber composition. Cells. 2022 Dec 2; 11(23):3910. doi: 10.3390/cells11233910.
  13. Dines HR, Nixon J, Lockey SJ, Herbert AJ, Kipps C, Pedlar CR, Day SH, Heffernan SM, Antrobus MR, Brazier J, Erskine RM, Stebbings GK, Hall ECR, Williams AG. Collagen gene polymorphisms previously associated with resistance to soft-tissue injury are more common in competitive runners than nonathletes. J Strength Cond Res. 2023 Apr; 37(4):799–805. doi: 10.1519/JSC.00000000000 04291.
  14. Guilherme JPLF, Semenova EA, Larin AK, Yusupov RA, Generozov EV, Ahmetov II. Genomic predictors of brisk walking are associated with elite sprinter status. Genes. 2022 Sep 23; 13(10):1710. doi: 10.3390/genes13101710 PubMed PMID: 36292594; PubMed Central PMCID: PMC9602420.
  15. Moreland E, Borisov OV, Semenova EA, Larin AK, Andryushchenko ON, Andryushchenko LB, Generozov EV, Williams AG, Ahmetov II. Polygenic profile of elite strength athletes. J Strength Cond Res. 2022 Sep 1; 36(9):2509–14. doi: 10.1519/JSC .0000000000003901 PubMed PMID: 33278272.
  16. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol. 1995 Jan 1; 57(1):289–300. doi: 10.1111/j.2517-6161.1995. tb02031.x.
  17. Wald A. Tests of statistical hypotheses concerning several parameters when the number of observations is large. Trans Am Math Soc. 1943; 54(3):426–82. doi: 10.1090/S0002-9947-1943 -0012401-3.
  18. Cockerham CC. An Extension of the concept of partitioning hereditary variance for analysis of covariances among relatives when epistasis is present. Genetics. 1954 Nov; 39(6):859–82. doi: 10.1093 /genetics/39.6.859 PubMed PMID: 17247525; PubMed Central PMCID: PMC1209694.
  19. Houweling PJ, Papadimitriou ID, Seto JT, Pérez LM, Coso JD, North KN, Lucia A, Eynon N. Is evolutionary loss our gain? The role of ACTN3 p.Arg577Ter (R577X) genotype in athletic performance, ageing, and disease. Hum Mutat. 2018 Dec; 39(12):1774–87. doi: 10.1002/humu .23663.
  20. Demirci B, Bulgay C, Ceylan Hİ, Öztürk ME, Öztürk D, Kazan HH, Ergun MA, Cerit M, Semenova EA, Larin AK, Generozov EV, Ahmetov II, Cepicka L. Association of ACTN3 R577X polymorphism with elite basketball player status and training responses. Genes. 2023 May 29; 14(6):1190. doi: 10.3390/genes14061190.
  21. Balberova OV, Shnayder NA, Bykov EV, Zakaryukin YE, Petrova MM, Soloveva IA, Narodova EA, Chumakova GA, Al-Zamil M, Asadullin AR, Vaiman EE, Trefilova VV, Nasyrova RF. Association of the ACTN3 gene’s single-nucleotide variant rs1815739 (R577X) with sports qualification and competitive distance in Caucasian athletes of the southern Urals. Genes. 2023 Jul 25; 14(8):1512. doi: 10.3390/genes14081512.
  22. Tharabenjasin P, Pabalan N, Jarjanazi H. Association of the ACTN3 R577X (rs1815739) polymorphism with elite power sports: A meta-analysis. Lammi MJ, editor. PLOS ONE. 2019 May 30; 14(5):e0217390. doi: 10.1371 /journal.pone.0217390.
  23. Costanzo L, Soto B, Meier R, Geraghty P. The biology and function of tissue inhibitor of metalloproteinase 2 in the lungs. Pulm Med. 2022; 2022:3632764. doi: 10.1155 /2022/3632764 PubMed PMID: 36624735; PubMed Central PMCID: PMC9825218.
  24. Jung JC, Wang PX, Zhang G, Ezura Y, Fini ME, Birk DE. Collagen fibril growth during chicken tendon development: matrix metalloproteinase-2 and its activation. Cell Tissue Res. 2009 Apr; 336(1):79–89. doi: 10.1007/s00441 -009-0755-4 PubMed PMID: 19221802; PubMed Central PMCID: PMC2746393.
  25. Minkwitz S, Schmock A, Kurtoglu A, Tsitsilonis S, Manegold S, Wildemann B, Klatte-Schulz F. Time-dependent alterations of MMPs, TIMPs and tendon structure in human Achilles tendons after acute rupture. Int J Mol Sci. 2017 Oct 20; 18(10):2199. doi: 10.3390 /ijms18102199 PubMed PMID: 29053586; PubMed Central PMCID: PMC5666880.
  26. Young WK, Briner W, Dines DM. Epidemiology of common injuries in the volleyball athlete. Curr Rev Musculoskelet Med. 2023 Apr 4; 16(6):229–34. doi: 10.1007/s12178-023-09826-2.
  27. Shibuya M. Vascular Endothelial Growth Factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies. Genes Cancer. 2011 Dec 1; 2(12):1097–105. doi: 10.1177 /1947601911423031.
  28. Lulińska-Kuklik E, Leźnicka K, Humińska-Lisowska K, Moska W, Michałowska-Sawczyn M, Ossowski Z, Maculewicz E, Cięszczyk P, Kaczmarczyk M, Ratkowski W, Ficek K, Zmijewski P, Leońska-Duniec A. The VEGFA gene and anterior cruciate ligament rupture risk in the Caucasian population. Biol Sport. 2019; 36(1):3–8. doi: 10.5114/biolsport.2018.78902.
  29. Rahim M, Gibbon A, Hobbs H, Van Der Merwe W, Posthumus M, Collins M, September AV. The association of genes involved in the angiogenesis-associated signaling pathway with risk of anterior cruciate ligament rupture: angiogenesis and ACL rupture risk. J Orthop Res. 2014 Dec; 32(12):1612–8. doi: 10.1002/jor.22705.
  30. Rahim M, Hobbs H, Van Der Merwe W, Posthumus M, Collins M, September AV. Investigation of angiogenesis genes with anterior cruciate ligament rupture risk in a South African population. J Sports Sci. 2018 Mar 4; 36(5):551–7. doi: 10.1080 /02640 414.2017.1322710.
  31. Salles JI, Duarte MEL, Guimarães JM, Lopes LR, Vilarinho Cardoso J, Aguiar DP, Machado Neto JO, Machado DE, Perini JA. Vascular Endothelial Growth Factor Receptor-2 polymorphisms have protective effect against the development of tendinopathy in volleyball athletes. Lucía A, editor. PLOS ONE. 2016 Dec 8; 11(12):e0167717. doi: 10.1371 /journal.pone.0167717.
  32. Ma W, Xin K, Chen K, Tang H, Chen H, Zhi L, Liu H. Relationship of common variants in VEGFA gene with osteonecrosis of the femoral head: A Han Chinese population based association study. Sci Rep. 2018 Nov 1; 8(1):16221. doi: 10.1038/s41598 -018-34352-4.
  33. Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y, Qin Q, Zhao B, Yang Y, Hui R. Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol. 2007 Aug; 50(8):760–7. doi: 10.1016/j.jacc .2007.04.074.
  34. Liu X, Zhu B, Li Y, Liu X, Guo S, Wang C, Li S, Wang D. The role of vascular endothelial growth factor in tendon healing. Front Physiol. 2021 Oct 25; 12:766080. doi: 10.3389/fphys .2021.766080.
  35. Boidin M, Dawson EA, Thijssen DHJ, Erskine RM. VEGFA rs2010963 GG genotype is associated with superior adaptations to resistance versus endurance training in the same group of healthy, young men. Mol Genet Genomics. 2023 Jan; 298(1):119–29. doi: 10.1007/s00438-022-01965-4.
  36. Chu M. Structural proteins: Genes for collagen. In: Encyclopedia of Life Sciences [Internet]. 1st edn. Wiley; 2011 [cited 2026 Jul 13]. Available from: https://onlinelibrary.wiley.com/ doi/10.1002/9780470015902. a0005023.pub2 doi: 10.1002 /9780470015902.a0005023.pub2.
  37. Izu Y, Birk DE. Collagen XII mediated cellular and extracellular mechanisms in development, regeneration, and disease. Front Cell Dev Biol. 2023 Mar 2; 11:1129000. doi: 10.3389 /fcell.2023.1129000.
  38. Cross B, Turner R, Pirmohamed M. Polygenic risk scores: An overview from bench to bedside for personalised medicine. Front Genet. 2022 Nov 11; 13:1000667. doi: 10.3389 /fgene.2022.1000667.
Copyright: Institute of Sport. This is an Open Access article distributed under the terms of the Creative Commons CC BY License (https://creativecommons.org/licenses/by/4.0/). This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
SUBMIT YOUR PAPER
Share
without publication fees
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications